121 related articles for article (PubMed ID: 30396381)
1. Drug likeness, targets, molecular docking and ADMET studies for some indolizine derivatives.
Belal A
Pharmazie; 2018 Nov; 73(11):635-642. PubMed ID: 30396381
[TBL] [Abstract][Full Text] [Related]
2. Exploring the novel heterocyclic derivatives as lead molecules for design and development of potent anticancer agents.
Azad I; Nasibullah M; Khan T; Hassan F; Akhter Y
J Mol Graph Model; 2018 May; 81():211-228. PubMed ID: 29609141
[TBL] [Abstract][Full Text] [Related]
3. In Silico Molecular Docking Analysis of Karanjin against Alzheimer's and Parkinson's Diseases as a Potential Natural Lead Molecule for New Drug Design, Development and Therapy.
Gnanaraj C; Sekar M; Fuloria S; Swain SS; Gan SH; Chidambaram K; Rani NNIM; Balan T; Stephenie S; Lum PT; Jeyabalan S; Begum MY; Chandramohan V; Thangavelu L; Subramaniyan V; Fuloria NK
Molecules; 2022 Apr; 27(9):. PubMed ID: 35566187
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and biological activities of indolizine derivatives as alpha-7 nAChR agonists.
Xue Y; Tang J; Ma X; Li Q; Xie B; Hao Y; Jin H; Wang K; Zhang G; Zhang L; Zhang L
Eur J Med Chem; 2016 Jun; 115():94-108. PubMed ID: 26994846
[TBL] [Abstract][Full Text] [Related]
5. Ginger components as new leads for the design and development of novel multi-targeted anti-Alzheimer's drugs: a computational investigation.
Azam F; Amer AM; Abulifa AR; Elzwawi MM
Drug Des Devel Ther; 2014; 8():2045-59. PubMed ID: 25364231
[TBL] [Abstract][Full Text] [Related]
6. Understanding the Action of Indolizines as Biologically Active Moieties: A Molecular Dynamics Study.
Szefler B; Czelen P; Diudea MV
Curr Comput Aided Drug Des; 2017; 13(1):22-29. PubMed ID: 27719631
[TBL] [Abstract][Full Text] [Related]
7. Inhibitory activities of indolizine derivatives: a patent review.
Dawood KM; Abbas AA
Expert Opin Ther Pat; 2020 Sep; 30(9):695-714. PubMed ID: 32684068
[TBL] [Abstract][Full Text] [Related]
8. Design, synthesis and biological evaluation of 2-acetyl-5-O-(amino-alkyl)phenol derivatives as multifunctional agents for the treatment of Alzheimer's disease.
Sang Z; Wang K; Wang H; Wang H; Ma Q; Han X; Ye M; Yu L; Liu W
Bioorg Med Chem Lett; 2017 Nov; 27(22):5046-5052. PubMed ID: 29033233
[TBL] [Abstract][Full Text] [Related]
9. Design, synthesis and biological evaluation of phthalimide-alkylamine derivatives as balanced multifunctional cholinesterase and monoamine oxidase-B inhibitors for the treatment of Alzheimer's disease.
Sang Z; Wang K; Wang H; Yu L; Wang H; Ma Q; Ye M; Han X; Liu W
Bioorg Med Chem Lett; 2017 Nov; 27(22):5053-5059. PubMed ID: 29033232
[TBL] [Abstract][Full Text] [Related]
10. Theoretical evaluation of ADMET properties for coumarin derivatives as compounds with therapeutic potential.
Żołek T; Maciejewska D
Eur J Pharm Sci; 2017 Nov; 109():486-502. PubMed ID: 28867490
[TBL] [Abstract][Full Text] [Related]
11. Repurposing of clinically proven bioactive compounds for targeted treatment of Alzheimer's disease using molecular docking approach.
Vasanth Kanth TLB; Raha A; Vijay Murali RM; Yuvatha N; Kumaran K; Kirubakaran R; ArulJothi KN
In Silico Pharmacol; 2023; 11(1):33. PubMed ID: 37920821
[TBL] [Abstract][Full Text] [Related]
12. Antimycobacterial activity of nitrogen heterocycles derivatives: 7-(pyridine-4-yl)-indolizine derivatives. Part VII
Olaru AM; Vasilache V; Danac R; Mangalagiu II
J Enzyme Inhib Med Chem; 2017 Dec; 32(1):1291-1298. PubMed ID: 29072097
[TBL] [Abstract][Full Text] [Related]
13. Computer-aided drug design and virtual screening of targeted combinatorial libraries of mixed-ligand transition metal complexes of 2-butanone thiosemicarbazone.
Khan T; Ahmad R; Azad I; Raza S; Joshi S; Khan AR
Comput Biol Chem; 2018 Aug; 75():178-195. PubMed ID: 29883916
[TBL] [Abstract][Full Text] [Related]
14. Design, synthesis, and biological evaluation of some novel indolizine derivatives as dual cyclooxygenase and lipoxygenase inhibitor for anti-inflammatory activity.
Shrivastava SK; Srivastava P; Bandresh R; Tripathi PN; Tripathi A
Bioorg Med Chem; 2017 Aug; 25(16):4424-4432. PubMed ID: 28669741
[TBL] [Abstract][Full Text] [Related]
15. Tetrahydroindolizinone NK1 antagonists.
Bao J; Lu H; Morriello GJ; Carlson EJ; Wheeldon A; Chicchi GG; Kurtz MM; Tsao KL; Zheng S; Tong X; Mills SG; DeVita RJ
Bioorg Med Chem Lett; 2010 Apr; 20(7):2354-8. PubMed ID: 20188553
[TBL] [Abstract][Full Text] [Related]
16. Novel indolizine derivatives with unprecedented inhibitory activity on human farnesyltransferase.
Dumea C; Belei D; Ghinet A; Dubois J; Farce A; Bîcu E
Bioorg Med Chem Lett; 2014 Dec; 24(24):5777-5781. PubMed ID: 25453818
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and estrogen receptor binding affinities of novel pyrrolo[2,1,5-cd]indolizine derivatives.
Jørgensen AS; Jacobsen P; Christiansen LB; Bury PS; Kanstrup A; Thorpe SM; Naerum L; Wassermann K
Bioorg Med Chem Lett; 2000 Oct; 10(20):2383-6. PubMed ID: 11055361
[TBL] [Abstract][Full Text] [Related]
18. Multiple Ligands Targeting Cholinesterases and β-Amyloid: Synthesis, Biological Evaluation of Heterodimeric Compounds with Benzylamine Pharmacophore.
Szałaj N; Bajda M; Dudek K; Brus B; Gobec S; Malawska B
Arch Pharm (Weinheim); 2015 Aug; 348(8):556-63. PubMed ID: 26032855
[TBL] [Abstract][Full Text] [Related]
19. Indolizine derivatives as HIV-1 VIF-ElonginC interaction inhibitors.
Huang W; Zuo T; Luo X; Jin H; Liu Z; Yang Z; Yu X; Zhang L; Zhang L
Chem Biol Drug Des; 2013 Jun; 81(6):730-41. PubMed ID: 23405965
[TBL] [Abstract][Full Text] [Related]
20. Assessment of the pharmacokinetic profile of novel s-triazine derivatives and their potential use in treatment of Alzheimer's disease.
Trifunović J; Borčić V; Vukmirović S; Mikov M
Life Sci; 2017 Jan; 168():1-6. PubMed ID: 27818183
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
